NO890245L - Isoxazoler med nootrop aktivitet. - Google Patents

Isoxazoler med nootrop aktivitet.

Info

Publication number
NO890245L
NO890245L NO89890245A NO890245A NO890245L NO 890245 L NO890245 L NO 890245L NO 89890245 A NO89890245 A NO 89890245A NO 890245 A NO890245 A NO 890245A NO 890245 L NO890245 L NO 890245L
Authority
NO
Norway
Prior art keywords
pct
nootrop
isoxazols
activity
sec
Prior art date
Application number
NO89890245A
Other languages
English (en)
Other versions
NO172120C (no
NO890245D0 (no
NO172120B (no
Inventor
Angelo Carenzi
Dario Chiarino
Davide Della Bella
Mauro Napoletano
Alberto Sala
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20589/87A external-priority patent/IT1205014B/it
Priority claimed from IT20590/87A external-priority patent/IT1205015B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NO890245D0 publication Critical patent/NO890245D0/no
Publication of NO890245L publication Critical patent/NO890245L/no
Publication of NO172120B publication Critical patent/NO172120B/no
Publication of NO172120C publication Critical patent/NO172120C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO890245A 1987-05-20 1989-01-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler NO172120C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT20589/87A IT1205014B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
IT20590/87A IT1205015B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
PCT/EP1988/000445 WO1988009330A1 (en) 1987-05-20 1988-05-19 Isoxazoles with nootropic activity

Publications (4)

Publication Number Publication Date
NO890245D0 NO890245D0 (no) 1989-01-19
NO890245L true NO890245L (no) 1989-01-19
NO172120B NO172120B (no) 1993-03-01
NO172120C NO172120C (no) 1993-06-09

Family

ID=26327590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890245A NO172120C (no) 1987-05-20 1989-01-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Country Status (10)

Country Link
US (1) US4985428A (no)
EP (1) EP0317588B1 (no)
JP (1) JPH02500365A (no)
AT (1) ATE65997T1 (no)
AU (1) AU599809B2 (no)
DE (1) DE3864124D1 (no)
DK (1) DK4389A (no)
FI (1) FI89266C (no)
NO (1) NO172120C (no)
WO (1) WO1988009330A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
ITMI20042187A1 (it) * 2004-11-16 2005-02-16 Zambon Spa Derivati isossazolici per allievare il dolore neiropatico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2024M (fr) * 1961-02-01 1963-09-23 Shionogi & Co Utilisation de dérivés de l'isoxazole pour le traitement des maladies mentales et particulierement des dépressions nerveuses.
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
ATE65997T1 (de) 1991-08-15
NO172120C (no) 1993-06-09
NO890245D0 (no) 1989-01-19
DE3864124D1 (de) 1991-09-12
WO1988009330A1 (en) 1988-12-01
DK4389D0 (da) 1989-01-06
NO172120B (no) 1993-03-01
FI89266C (fi) 1993-09-10
FI890173A (fi) 1989-01-13
FI890173A0 (fi) 1989-01-13
EP0317588B1 (en) 1991-08-07
US4985428A (en) 1991-01-15
FI89266B (fi) 1993-05-31
AU1786988A (en) 1988-12-21
AU599809B2 (en) 1990-07-26
JPH02500365A (ja) 1990-02-08
DK4389A (da) 1989-01-06
EP0317588A1 (en) 1989-05-31

Similar Documents

Publication Publication Date Title
NO890408D0 (no) 3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse.
DE69104777T2 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DK249389A (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
NO911600D0 (no) Fremgangsmaate for fremstilling av n-(3-fluor-2-fosfonyl-metoksypropyl)-derivater av heterocykliske purin- og pyrimidinbaser.
ES555992A0 (es) Procedimiento para la obtencion de e-isomeros de derivados y peptidos de n<-(2-ciano-2-alcoximino-acetil)-aminoacidos
DE68929321T2 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
DE58903964D1 (de) Fluessige orale formulierung.
NO890245L (no) Isoxazoler med nootrop aktivitet.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
ES510546A0 (es) "procedimiento de preparar derivados de n-(n-metil-rn(n-aminosulfenil disubstituido)carbamoil)oxi)tioacetamidato de s-metilo".
ATE57526T1 (de) P-acylaminobenzamide.
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
SE8703308D0 (sv) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
ATE89732T1 (de) Bakterientoetende gemische.
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
DK48489D0 (da) Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
JPS6485952A (en) Active compound for remedy of cardiovascular system
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.
SU1586154A1 (ru) 3-(2,4-Дихлорфенил)-4-оксо-3a,4,6,6a-тетрагидрофуро-[3,4-d]изоксазол, проявляющий антигельминтную и анальгетическую активность